Table 3.

Reasons cited for not giving IV/IP chemotherapy in patients who received IV chemotherapy (N=69).

Primary Reason Cited for Not Giving IV/IP Chemotherapy	n (%)
Postoperative issue	18 (26%)
Wound infection	2 (3%)
Delayed wound healing	10 (15%)
Performance status	6 (9%)
Baseline comorbidities	10 (15%)
IP port complication	8 (12%)
Clinical trial	6 (9%)
Patient choice	6 (9%)
Ileostomy present	5 (7%)
Intra-abdominal adhesions	3 (4%)
Other	9 (13%)
Disease thought to be localized	1 (1.4%)
Stage III by PALN involvement	1 (1.4%)
Avoid delay for IP port placement	1 (1.4%)
Severe taxane allergy with first infusion	2 (3%)
Recent cerebrovascular accident	1 (1.4%)
Tenckhoff catheter in place	1 (1.4%)
Extensive nature of PDS	1 (1.4%)
Recent LBO requiring stent	1 (1.4%)
Not stated	4 (6%)

IP = intraperitoneal, PALN = para-aortic lymph node, PDS = primary debulking surgery, LBO = large bowel obstruction.